Randrup A, Mogilnicka E
Pol J Pharmacol Pharm. 1976 Nov-Dec;28(6):551-6.
Amantadine (D1) and 1,3-dimethyl-5-aminoadamantane (D145) as examples of new drugs with special actions on dopamine systems are discussed. D1 or D145 decreased significantly apomorphine or amphetamine-induced stereotypy in rats but in experiments with chronic pretreatment with amantadines -- potentiation of stereotypy was observed. D145 (20 mg/kg) abolished stereotypy in these conditions. In biochemical experiments D1 or D145 were neither like apomorphine nor like amphetamine. Its concluded that D1 and D145 in addition to their amine releasing properties have the ability partially to occupy the dopaminergic receptor.
金刚烷胺(D1)和1,3 - 二甲基 - 5 - 氨基金刚烷(D145)作为对多巴胺系统有特殊作用的新药实例进行了讨论。D1或D145可显著降低阿扑吗啡或苯丙胺诱导的大鼠刻板行为,但在对金刚烷胺进行慢性预处理的实验中,观察到刻板行为增强。在这些条件下,D145(20毫克/千克)消除了刻板行为。在生化实验中,D1或D145既不像阿扑吗啡也不像苯丙胺。得出的结论是,D1和D145除了具有胺释放特性外,还具有部分占据多巴胺能受体的能力。